Yamaguchi H, Kato T, Honda M, Hamada K, Todate Y, Ishikawa Y, Seto I, Tominaga T, Machida M, Takagawa Y, Takayama K, Suzuki M, Kikuchi Y, Teranishi Y, Murakami M, Konno S Clinical outcomes and factors involved in the local control of proton beam therapy for oligometastatic liver tumors in patients with colorectal cancer Strahlenther Onkol. 2023 ;199:304-312.

Yamaguchi H, Kato T, Ishikawa Y, Takemasa K, Narita Y, Takagawa Y, Seto I, Machida M, Yuntao Dai, Azami Y, Tominaga T, Takayama K, Suzuki M, Kikuchi Y, Murakami M Safety of hydrogel spacers for rectal wall protection in patients with prostate cancer: A retrospective analysis of 200 consecutive cases Int J Urol. 2023.

Kato R, Kato T, Narita Y, Sasaki S, Takayama K, Murakami M. Identification of Induced Radionuclides Produced from Dental Metals in Proton Beam Therapy for Head and Neck Cancer. Adv Radiat Oncol. 2022;8:101153.

Kato T, Ono T, Narita Y, Komori S, Murakami M. Dose-volume comparison of intensity modulated proton therapy and volumetric modulated arc therapy for cervical esophageal cancer. Med Dosim. 2022 Autumn;47:216-221.

Yamaguchi H, Kato T, Honda M, Hamada K, Seto I, Tominaga T,  Takagawa Y, Takayama K, Suzuki M, Kikuchi Y,  Teranishi Y, Murakami M. Effectiveness of proton beam therapy for unresectable liver oligometastatic recurrence in patients with postoperative esophagus cance J Radiat Res. (IF：2.857) 2023 May ;64:582-589.

Yamaguchi H, Kato T, Ishikawa Y, Takemasa K, Narita Y, Takagawa Y, Seto I, Machida M, Yuntao Dai, Azami Y, Tominaga T, Takayama K, Suzuki M, Kikuchi Y, Murakami M. Safety and challenges of hydrogel spacers for rectal wall protection in patients with prostate cancer: A retrospective analysis of 200 consecutive cases/ Int J Urol. Int J Urol. （IF：3.011） 2023 ;30:401-407.

Yamaguchi H, Kato T, Honda M,  Hamada K, Todate Y, Ishikawa Y, Seto I, Tominaga T,  Machida M, Takagawa Y, Takayama K, Suzuki M, Kikuchi Y,  Teranishi Y, Murakami M,  Konno S. Clinical outcomes and factors involved in the local control of proton beam therapy for oligometastatic liver tumors in patients with colorectal cancer/ Strahlenther Onkol. （IF:4.003） 2023 ;199:304-312.

Ishikawa Y, Morita K, Yamaguchi H, Kato T, Suzuki M, Seto I, Machida M, Takayama K, Tominaga T, Takagawa Y, Nakajima M, Teranishi Y, Kikuchi Y, Murakami M Proton Beam Therapy With Space-Making Surgery (Omental Plombage) for Oligorecurrent Liver Metastasis of Esophageal Adenocarcinoma Cureus. 2022 ;14:e31656.

Kitabatake T, Takayama K, Tominaga T, Hayashi Y, Seto I, Yamaguchi H, Suzuki M, Wada H, Kikuchi Y, Murakami M, Mitsudo K Treatment outcomes of proton beam therapy combined with retrograde intra-arterial infusion chemotherapy for locally advanced oral cancer in the elderly Int J Oral Maxillofac Surg. 2022 ;51:1264-1272.

Ishikawa Y, Suzuki M, Yamaguchi H, Seto I, Machida M, Takagawa Y, Jingu K , Kikuchi Y, Murakami M Successful treatment with proton beam therapy for a solitary sternal metastasis of breast cancer: a case report J Med Case Rep. 2022 ;16:111.

Ishikawa Y, Suzuki M, Yamaguchi H, Seto I, Machida M, Takagawa Y, Jingu K, Kikuchi Y, Murakami M Long-term survival after definitive proton beam therapy for oligorecurrent esophageal squamous cell carcinoma: a case report J Med Case Rep. 2022 ;16:68.

Narita Y, Kato T, Takemasa K, Sato H, Ikeda T, Harada T, Oyama S, Murakami M. Dosimetric impact of simulated changes in large bowel content during proton therapy with simultaneous integrated boost for locally advanced pancreatic cancer. J Appl Clin Med Phys. 2021 ;22:90-98.

Narita Y, Kato T, Ono T, Oyama S, Yamazaki Y, Ouchi H, Takemasa K, Murakami M. Trend analysis of the dosimetric impact of anatomical changes during proton therapy for maxillary sinus carcinoma. J Appl Clin Med Phys. 2021 ;22:298-306.

Kato T, Sagara T, Komori S, Kato R, Takeuchi A, Narita Y. Dosimetric properties of a newly developed thermoluminescent sheet-type dosimeter for clinical proton beams. J Appl Clin Med Phys. 2021 ;22:158-165.

Takemasa K, Kato T, Narita Y, Kato M, Yamazaki Y, Ouchi H, Oyama S, Yamaguchi H, Wada H, Murakami M. The impact of different setup methods on the dose distribution in proton therapy for hepatocellular carcinoma. J Appl Clin Med Phys. 2021 ;22:63-71.

Sagara T, Kato T, Murakami M. Biological impact of dosimetric perturbations of a fiducial marker and the daily number of fields in proton therapy for prostate cancer. Biomed Phys Eng Express. 2021 ;7:025007.

Sato H, Kato T, Motoyanagi T, Takemasa K, Narita Y, Kato M, Matsumoto T, Oyama S, Yamaguchi H, Wada H, Murakami M. Preliminary analysis of prostate positional displacement using hydrogel spacer during the course of proton therapy for prostate cancer. J Radiat Res. 2021;62:294-299.

Ishikawa Y, Suzuki M, Yamaguchi H, Seto I, Machida M, Takagawa Y, Jingu K, Kikuchi Y, Murakami M A long-term survival case with proton beam therapy for advanced sphenoid sinus cancer with hypopituitarism Int Cancer Conf J. 2021 Nov ;11:75-80.

Yamaguchi H, Honda M, Hamada K, Kobayashi H, Todate Y, Seto I, Takayama K, Suzuki M, Wada H, Kikuchi Y, Murakami M The effectiveness of proton beam therapy for liver metastatic recurrence in gastric cancer patients./Jpn Jpn J Clin Oncol. 2020;50:903-908.

Azami Y, Hayashi Y, Nakamura T, Kimura K, Yamaguchi H, Ono T,Takayama K, Hirose K, Yabuuchi T, Suzuki M, Hatayama Y, Hareyama M, Kikuchi Y, Fuwa N Proton Beam Therapy for Locally Recurrent Parotid Gland Cancer Indian J Otolaryngol Head Neck Surg. 2019 ;71:49-54.

Takayama K, Kato T, Nakamura T, Azami Y, Ono T, Suzuki M, Takada A, Yamaguchi H, Seto I, Nakasato T, Wada H, Kikuchi Y, Mitsudo K, Fuwa N, Murakami M Proton Beam Therapy Combined with Intra-Arterial Infusion Chemotherapy for Stage IV Adenoid Cystic Carcinoma of the Base of the Tongue Cancers (Basel). 2019 ;11:1413.

Ono T, Nakamura T, Azami Y, Suzuki M, Wada H, Kikuchi Y, Murakami M, Nemoto K Proton beam therapy is a safe and feasible treatment for patients with second primary lung cancer after lung resection Thorac Cancer. 2019 ;10:289-295.

Narita Y, Kato T, Ono T, Oyama S, Komori S, Arai K, Abe Y, Harada T, Nakamura T, Wada H, Kikuchi Y, Murakami M, Hosokawa Y. Effect of anatomical change on dose distribution during radiotherapy for maxillary sinus carcinoma: passive scattering proton therapy versus volumetric-modulated arc therapy. Br J Radiol. 2018 ;92:20180273.

Endo H, Takayama K, Mitsudo K, Nakamura T, Seto I, Yamaguchi H, Ono T, Suzuki M, Azami Y, Wada H, Murakami M, Tohnai I Proton Beam Therapy in Combination with Intra-Arterial Infusion Chemotherapy for T4 Squamous Cell Carcinoma of the Maxillary Gingiva Cancers (Basel). 2018;10:333.

Ono T, Nakamura T, Yamaguchi H, Azami Y,Takayama K, Suzuki M, Wada H, Kikuchi Y, Murakami M, Nemoto K Clinical results of proton beam therapy for elderly patients with non-small cell lung cancer Radiat Oncol. 2018 ;13:19.

Kimura K, Nakamura T, Ono T, Azami Y, Suzuki M, Wada H, Takayama K, Endo H, Takeyama T, Hirose K, Takai Y, Kikuchi Y Clinical results of proton beam therapy for hepatocellular carcinoma over 5 cm Hepatol Res. 2017;47:1368-1374.

Hayashi Y, Nakamura T, Mitsudo K, Kimura K, Yamaguchi H, Ono T, Azami Y, Takayama K, Hirose K, Yabuuchi T, Suzuki M, Hatayama Y, Kikuchi Y, Wada H, Fuwa N, Hareyama M,Tohnai I Re-irradiation using proton beam therapy combined with weekly intra-arterial chemotherapy for recurrent oral cancer Asia Pac J Clin Oncol. 2017;13:e394-e401.

Ono T, Yabuuchi T, Nakamura T, Kimura K, Azami Y, Hirose K, Suzuki M, Wada H, Kikuchi Y, Nemoto K High Dose Hypofractionated Proton Beam Therapy is a Safe and Feasible Treatment for Central Lung Cancer Radiol Oncol. 201716;51:324-330.

Hatayama Y, Nakamura T, Suzuki M, Azami Y, Ono T, Yabuuchi T, Hayashi Y, Kimura K, Hirose K, Wada H, Hareyama M, Kikuchi Y, Takai Y Clinical Outcomes and Prognostic Factors of High-Dose Proton Beam Therapy for Peripheral Stage I Non-Small-Cell Lung Cancer Clin Lung Cancer. 2016;17:427-432.

Takada A, Nakamura T, Takayama K, Makita C, Suzuki M, Azami Y, Kato T, Tsukiyama I, Hareyama H, Kikuchi Y, Daimon T, Toyomasu Y, Ii N, Nomoto Y, Sakuma H, Fuwa N Preliminary treatment results of proton beam therapy with chemoradiotherapy for stage I-III esophageal cancer Cancer Med. 2016 ;5:506-15.

Hayashi Y, Nakamura T, Mitsudo K, Yamaguchi H, Ono T, Azami Y, Takayama K, Suzuki M, Hatayama Y, Tsukiyama I, Hareyama M, Kikuchi Y, Fuwa N, Tohnai I Retrograde intra-arterial chemotherapy and daily concurrent proton beam therapy for recurrent oral cavity squamous cell carcinoma: Analysis of therapeutic results in 46 cases Head Neck. 2016;38:1145-51.

Ono T, Hareyama M, Nakamura T, Kimura K, Hayashi Y, Azami Y, Hirose K, Hatayama Y, Suzuki M, Wada H, Kikuchi Y, Nemoto K The clinical results of proton beam therapy in patients with idiopathic pulmonary fibrosis: a single center experience Radiat Oncol. 2016 18;11:56.

Ishikawa Y, Nakamura T, Kato T, Kadoya N, Suzuki M, Azami Y, Hareyama M, Kikuchi Y, Jingu K Dosemetric Parameters Predictive of Rib Fractures after Proton Beam Therapy for Early-Stage Lung Cancer Tohoku J Exp Med. 2016 ;238:339-45.

Takayama K, Nakamura T, Takada A, Makita C, Suzuki M, Azami Y, Kato T, Hayashi Y, Ono T, Toyomasu Y, Hareyama M, Kikuchi Y, Daimon T, Mitsudo K, Tohnai I, Fuwa N Treatment results of alternating chemoradiotherapy followed by proton beam therapy boost combined with intra-arterial infusion chemotherapy for stage III-IVB tongue cancer J Cancer Res Clin Oncol. 2016 ;142:659-67.

Nakamura T, Azami Y, Ono T, Yamaguchi H, Hayashi Y, Suzuki M, Hatayama Y, Tsukiyama I, Hareyama M, Kikuchi Y, Takayama K, Fuwa N Preliminary results of proton beam therapy combined with weekly cisplatin intra-arterial infusion via a superficial temporal artery for treatment of maxillary sinus carcinoma Jpn J Clin Oncol. 2016 ;46:46-50.

Ono T, Nakamura T, Azami Y, Yamaguchi H, Hayashi Y, Suzuki M, Hatayama Y, Tsukiyama I, Hareyama M, Kikuchi Y, Nemoto K Clinical results of proton beam therapy for twenty older patients with esophageal cancer Radiol Oncol. 2015 27;49:371-8.

Y Hatayama, T Nakamura, M Suzuki, Y Azami, T Ono, H Yamaguchi, Y Hayashi, I Tsukiyama, M Hareyama, Y Kikuchi, Y Takai Preliminary results of proton-beam therapy for stage III non-small-cell lung cancer Curr Oncol. 2015 ;22:e370-5.

Makita C, Nakamura T, Takada A, Takayama K, Suzuki M, Azami Y, Kato T, Tsukiyama I, Hareyama M, Kikuchi Y, Daimon T, Hata M, Inoue T, Fuwa N High-dose proton beam therapy for stage I non-small cell lung cancer: Clinical outcomes and prognostic factors Acta Oncol. 2015 ;54:307-14.

Makita C, Nakamura T, Takada A, Takayama K, Suzuki M, Ishikawa Y, Azami Y, Kato T, Tsukiyama I, Kikuchi Y, Hareyama M, Murakami M, Fuwa N, Hata M, Inoue T Clinical outcomes and toxicity of proton beam therapy for advanced cholangiocarcinoma Radiat Oncol. 2014 14;9:26.